Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy of the Full Face Applications of Variable Doses of a Commercial Botulinum Toxin Type a (Dysport®)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2009 by Brazilan Center for Studies in Dermatology.
Recruitment status was  Active, not recruiting
Information provided by:
Brazilan Center for Studies in Dermatology Identifier:
First received: December 15, 2009
Last updated: July 6, 2010
Last verified: December 2009
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: November 2010
  Estimated Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)